Exposure of mouse embryonic fibroblasts (MEF) to anti-cancer agents - such as doxorubicin or histone deacetylase inhibitors - also led to increased phosphorylation of eIF2α, albeit a sustained rather than a transient one [25,26]. This evidence concerns the gene EIF2A and cancer.